EUVIMEDEUVIMED entdecken
Open Access

Cxcl10 is protective during mouse-adapted SARS-CoV-2 infection

Shamik Majumdar iD, Joseph D Weaver, Sergio M Pontejo iD, Mahnaz Minai, Xinping Lu, Ji-Liang Gao, Gibran Holmes, Reed Johnson, Hongwei Zhang, Brian L Kelsall, Joshua M Farber, Derron A Alves und 1 weitere

Journal of Leukocyte Biology · 2025

DOI: 10.1093/jleuko/qiae252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Shamik Majumdar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health…. Hauptthemen laut MEDLINE: Chemokine CXCL10, COVID-19, SARS-CoV-2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institute of Allergy and Infectious Diseases, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of the coronavirus disease 2019 (COVID-19) pandemic, remains endemic worldwide. Circulating levels of the chemokine CXCL10 are strongly positively associated with poor outcome; however, its precise role in SARS-CoV-2 pathogenesis and its suitability as a therapeutic target have remained undefined. Here, we challenged mice genetically deficient in Cxcl10 with a mouse-adapted strain of SARS-CoV-2. Infected male, but not female, Cxcl10−/− mice displayed increased mortality compared to wild type controls. Histopathological damage, inflammatory gene induction, and virus load in the lungs of male mice were not broadly influenced by Cxcl10 deficiency. However, accumulation of B and T lymphocytes in the lung parenchyma of infected mice was reduced in the absence of Cxcl10. Thus, during acute SARS-CoV-2 infection, Cxcl10 regulates lymphocyte infiltration in lung and confers protection against mortality. Our preclinical model results do not support targeting CXCL10 therapeutically in severe COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CXCL10COVID-19SARS-CoV-2AnimalsMiceMaleFemaleLungMice, KnockoutDisease Models, AnimalMice, Inbred C57BLViral LoadHumansT-Lymphocytes

Stichwörter der Autor:innen

COVID-19chemokinechemokine receptorcytokinelymphocytes

Substanzen

Chemokine CXCL10Cxcl10 protein, mouse

Autor:innen und Institutionen

  • Molecular Signaling Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, United States.
  • Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20852, United States.
  • Inflammation Biology Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, United States.
  • SARS-CoV-2 Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, United States.
  • Mucosal Immunobiology Section, Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, United States.

ORCID-Profile: Shamik Majumdar, Sergio M Pontejo, Philip M Murphy

Förderung

  • NHLBI NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • NIH HHS
  • Division of Intramural Research
  • National Institutes of Health

Zitieren

APA

Majumdar, S., Weaver, J. D., Pontejo, S. M., Minai, M., Lu, X., Gao, J. L., Holmes, G., Johnson, R., Zhang, H., Kelsall, B. L., Farber, J. M., Alves, D. A., & Murphy, P. M. (2025). Cxcl10 is protective during mouse-adapted SARS-CoV-2 infection. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae252

Vancouver

Majumdar S, Weaver JD, Pontejo SM, Minai M, Lu X, Gao JL, et al. Cxcl10 is protective during mouse-adapted SARS-CoV-2 infection. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiae252

BibTeX
@article{Majumdar2025,
  author = {Majumdar, Shamik and Weaver, Joseph D and Pontejo, Sergio M and Minai, Mahnaz and Lu, Xinping and Gao, Ji-Liang and Holmes, Gibran and Johnson, Reed and Zhang, Hongwei and Kelsall, Brian L and Farber, Joshua M and Alves, Derron A and Murphy, Philip M},
  title = {Cxcl10 is protective during mouse-adapted SARS-CoV-2 infection},
  journal = {Journal of Leukocyte Biology},
  year = {2025},
  doi = {10.1093/jleuko/qiae252}
}
Kostenlos starten →